

Active ingredients | Status | Update | Specialty |
retinol palmitate | Supply tension | 04/07/2025 | Vitamin A Provepharm 100 000 I.U./2 ml, solution for injection (I.M.) |
sugammadex sodique | Supply tension | 04/07/2025 | Sugammadex 100 mg/mL, solution for injection 5 ml vials |
fusidic acid | Out of stock | 04/07/2025 | Fucithalmic 1%, ophthalmic gel |
ondansetron | Out of stock | 04/07/2025 | Zophren 4 mg/5 ml, syrup |
lithium (carbonate) | Available again | 04/07/2025 | Teralithe 250 mg, scored tablet |
carbamazepine | Out of stock | 03/07/2025 | Carbamazepine Viatris L.P. 400 mg, extended release scored tablet |
carbamazepine | Out of stock | 03/07/2025 | Carbamazepine Viatris L.P. 200 mg, extended release scored tablet |
insulin aspart ((yeast/saccharomyces cerevisiae)) | Supply tension | 03/07/2025 | Novorapid Pumpcart 100 units/ml, solution for injection in cartridge |
peginterferon alfa-2a | Supply tension | 03/07/2025 | Pegasys 90 micrograms, 135 micrograms and 180 micrograms solution for injection in pre filled syringe |
disopyramide (phosphate) | Available again | 03/07/2025 | Rythmodan 250 mg sustained release, coated tablet |
mitomycin | Supply tension | 03/07/2025 | Mitomycin Accord 20 mg, powder for solution for injection / infusion or intravesical route |
human coagulation factor Willebrand | Supply tension | 03/07/2025 | Wilfactin 100 IU/mL, powder and solvent for solution for injection |
dexamethasone (sodium phosphate) | Supply tension | 02/07/2025 | Dexocol 1 mg/mL, eye drops solution |
tranexamic acid | Supply tension | 02/07/2025 | Exacyl 500 mg, film coated tablet |
potassium (bicarbonate)/potassium (citrate) | Available again | 02/07/2025 | Sibnayal 8 mEq, sustained release granules |
carbamazepine | Supply tension | 01/07/2025 | Tegretol L.P. 400 mg, extended release scored film coated tablet |
methylphénidate (chlorhydrate de) | Supply tension | 01/07/2025 | Méthylphénidate Biogaran, comprimé à libération prolongée |
colchicine, opium (powder), tiemonium (metilsulfate) | Supply tension | 01/07/2025 | Colchimax, scored film coated tablet and Colchicine Opocalcium 1 mg, scored tablet |
naloxegol (oxalate) | Out of stock | 01/07/2025 | Moventig 25 mg, film coated tablet |
fluorouracil | Out of stock | 01/07/2025 | Fluorouracil Pfizer 50 mg/ml, dilutable solution for infusion 100 ml bottle |
disopyramide (phosphate) | Out of stock | 30/06/2025 | Rythmodan 100 mg, capsule |
praziquantel | Available again | 30/06/2025 | Biltricide 600 mg, film coated quadrisectible tablet |
acetazolamide | Available again | 30/06/2025 | Diamox 250 mg, scored tablet |
Supply tension | 30/06/2025 | Repevax, suspension for injection in pre filled syringe. Diphtheria, tetanus, pertussis (acellular, multicomponent) and poliomyelitis vaccine (inactivated), (adsorbed, reduced antigen content) |
Active ingredients |
| Date of last notification | Type of reason | AM designation | |
Fampridine | Change notification | 04.07.2025 | Other | Fampyra 10 mg prolonged-release tablets – OP28(2×14)(Bl) | |
Dexamethasone; neomycin sulfate; polymyxin B sulfate | Change notification | 04.07.2025 | Production problem | Isopto-Max | |
Olanzapine embonate monohydrate | First notification | 04.07.2025 | Production problem | ZYPADHERA 210 mg powder and solvent for the preparation of a suspension for depot injection – OP(483mg+3ml) | |
Acetylcholine chloride | Change notification | 04.07.2025 | Production problem | Miochol-E Powder and solvent for the preparation of an instillation solution for intraocular use | |
Terazosin hydrochloride dihydrate | Change notification | 04.07.2025 | Other | Heitrin 1mg | |
Terazosin hydrochloride dihydrate | Change notification | 04.07.2025 | Other | Heitrin 5mg | |
Terazosin hydrochloride dihydrate | Change notification | 04.07.2025 | Other | Heitrin 2mg | |
Nitrendipine | Change notification | 04.07.2025 | Production problem | Nitrendipine Aristo 10 mg film-coated tablets | |
Rivastigmine hydrogentartrate | Change notification | 04.07.2025 | Production problem | Rivastigmine Aurobindo 6 mg hard capsules | |
Celecoxib | Change notification | 04.07.2025 | Production problem | Celecoxib Aurobindo 200 mg hard capsules | |
Duloxetine hydrochloride | Change notification | 04.07.2025 | Production problem | Duloxetine PUREN 40 mg enteric-coated hard capsules | |
Duloxetine hydrochloride | Change notification | 04.07.2025 | Production problem | Duloxetine Aurobindo 60 mg enteric-coated hard capsules | |
Methylphenidate hydrochloride | Change notification | 03.07.2025 | Production problem | Methysym | |
Methylphenidate hydrochloride | Change notification | 03.07.2025 | Production problem | Methysym | |
Methylphenidate hydrochloride | Change notification | 03.07.2025 | Production problem | Methysym | |
Methylphenidate hydrochloride | Change notification | 03.07.2025 | Production problem | Methysym | |
Methylphenidate hydrochloride | Change notification | 03.07.2025 | Production problem | Methysym | |
Methylphenidate hydrochloride | Change notification | 03.07.2025 | Production problem | Methysym | |
Terazosin hydrochloride dihydrate | Change notification | 03.07.2025 | Other | Tera TAD 2mg | |
Terazosin hydrochloride dihydrate | Change notification | 03.07.2025 | Other | Tera TAD 5mg | |
Terazosin hydrochloride dihydrate | Change notification | 03.07.2025 | Other | Tera TAD 10mg | |
Cefotaxime sodium | First notification | 03.07.2025 | Production problem | Cefotaxime-saar 2 g Powder for solution for injection or infusion | |
Fluoxetine hydrochloride | First notification | 03.07.2025 | Other | Fluoxetine beta 40 | |
Fluoxetine hydrochloride | First notification | 03.07.2025 | Other | Fluoxetine beta 20 | |
Zoledronic acid monohydrate | First notification | 03.07.2025 | Other | Zole – 1 A Pharma 5 mg/100 ml solution for infusion | |
Zoledronic acid monohydrate | First notification | 03.07.2025 | Other | Aclasta 5 mg solution for infusion – OP(1x100ml) | |
Insulin human ((with manufacturing details)) | First notification | 03.07.2025 | Other | Huminsulin Profile III KwikPen 100 IU/ml injection suspension | |
Quetiapine fumarate (Ph.Eur.) | First notification | 03.07.2025 | Production problem | Quetiapine Glenmark 150 mg prolonged-release tablets | |
Mometasone furoate (Ph.Eur.) | Change notification | 03.07.2025 | Production problem | Mometasone Glenmark 1mg/g ointment | |
Urapidil | Change notification | 03.07.2025 | Other | Urapidil Stragen 30 mg delayed-release hard capsules | |
Urapidil | Change notification | 03.07.2025 | Other | Urapidil Stragen 60 mg delayed-release hard capsules | |
Thioctic acid trometamol salt (1:1) | Change notification | 03.07.2025 | Other | Thioctacid 600 T | |
Solifenacin succinate | Change notification | 03.07.2025 | Production problem | Solifenacin succinate Aurobindo 5 mg film-coated tablets | |
Prednisolone acetate | Change notification | 03.07.2025 | Production problem | Predni-POS 1 % | |
Fluorometholone | Change notification | 03.07.2025 | Production problem | fluoropos | |
Hydrocortisone acetate (Ph.Eur.) | Change notification | 03.07.2025 | Production problem | Hydrocortisone POS N 2.5% | |
Dexamethasone dihydrogen phosphate disodium (Ph.Eur.); gentamicin sulphate | Change notification | 03.07.2025 | Production problem | Dexa-Gentamicin | |
Acyclovir | Change notification | 03.07.2025 | Production problem | Virupos | |
Clarithromycin | Change notification | 03.07.2025 | Production problem | CLARITHROMYCIN BASICS 250 mg/5 ml granules for the preparation of an oral suspension | |
Esomeprazole hemimagnesium | Change notification | 03.07.2025 | Production problem | ESOMEPRAZOL BASICS 40 mg gastro-resistant hard capsules | |
Esomeprazole hemimagnesium | Change notification | 03.07.2025 | Production problem | ESOMEPRAZOL BASICS 20 mg enteric-coated hard capsules | |
Insulin lispro | First notification | 03.07.2025 | Other | Liprolog 100 E/ml solution for injection in cartridge – OP(5x3ml) | |
Anti-human T-lymphocyte immunoglobulin from horse | First notification | 03.07.2025 | Other | Atgam | |
Fluorouracil | Change notification | 03.07.2025 | Other | Benda-5 FU | |
Vancomycin hydrochloride | Change notification | 03.07.2025 | Production problem | Vancomycin Lyomark 1000 mg powder for concentrate for solution for infusion or oral solution | |
Vancomycin hydrochloride | Change notification | 03.07.2025 | Production problem | Vancomycin Lyomark 500 mg | |
Fluorouracil | Change notification | 03.07.2025 | Other | Fluorouracil Hikma 50 mg/ml solution for injection | |
Sodium (methylprednisolone-21-succinate) | Change notification | 02.07.2025 | Other | Urbason solubile forte 1000 mg | |
Insulin glargine | Change notification | 02.07.2025 | Other | Semglee | |
Salbutamol sulphate | Change notification | 02.07.2025 | Other | Sultanol metered dose aerosol | |
Insulin glargine | First notification | 02.07.2025 | Other | Semglee 100 units/ml solution for injection in prefilled pen – OP(5x3ml) | |
Ampicillin sodium | Change notification | 02.07.2025 | Production problem | Ampicillin Eberth 2 g powder for solution for injection/infusion | |
Ampicillin sodium | Change notification | 02.07.2025 | Production problem | Ampicillin Eberth 500 mg powder for solution for injection/infusion | |
Fosfomycin sodium (Ph.Eur.) | Change notification | 02.07.2025 | Production problem | Fosfomycin Eberth 2 g powder for solution for infusion | |
Fosfomycin sodium (Ph.Eur.) | Change notification | 02.07.2025 | Production problem | Fosfomycin Eberth 4 g powder for solution for infusion | |
Epoetin beta | First notification | 02.07.2025 | Other | NeoRecormon 3000 IU solution for injection in prefilled syringe – OP6 | |
Ibandronate sodium monohydrate | Change notification | 02.07.2025 | Other | Bondronat 50 mg film-coated tablets – OP28 | |
Methylphenidate hydrochloride | First notification | 02.07.2025 | Other | Methylphenidate AL 27 mg prolonged-release tablets | |
Ipratropium bromide (Ph.Eur.) | Change notification | 02.07.2025 | Production problem | Ipratropium Teva 250 micrograms / 1 ml solution for nebulizer | |
Buprenorphine | Change notification | 02.07.2025 | Other | Buprenorphine AWD Matrix 70 microgram/h transdermal patch | |
Fluoxetine hydrochloride | First notification | 02.07.2025 | Production problem | Fluoxetine Stada 20 mg tablets for oral suspension | |
Ribavirin | First notification | 02.07.2025 | Other | Ribavirin-ratiopharm 400 mg film-coated tablets | |
Ribavirin | Change notification | 02.07.2025 | Other | Ribavirin-ratiopharm 200 mg film-coated tablets | |
Buprenorphine | Change notification | 02.07.2025 | Other | Buprenorphine-ratiopharm 70 microgram/h transdermal patch | |
Buprenorphine | Change notification | 02.07.2025 | Other | Buprenorphine-ratiopharm 52.5 micrograms/h transdermal patch | |
Buprenorphine | Change notification | 02.07.2025 | Other | Buprenorphine-ratiopharm 35 micrograms/h transdermal patch | |
Aprepitant | First notification | 02.07.2025 | Production problem | Aprepitant STADA 125 mg and 80 mg hard capsules | |
Rizatriptan benzoate | Change notification | 01.07.2025 | Production problem | Rizatriptan Glenmark 5 mg tablets | |
Rizatriptan benzoate | Change notification | 01.07.2025 | Production problem | Rizatriptan Glenmark 5 mg orodispersible tablets | |
Rizatriptan benzoate | Change notification | 01.07.2025 | Production problem | Rizatriptan Glenmark 10 mg orodispersible tablets | |
Rizatriptan benzoate | Change notification | 01.07.2025 | Production problem | Rizatriptan Glenmark 10 mg tablets | |
Quetiapine fumarate (Ph.Eur.) | Change notification | 01.07.2025 | Production problem | Quetiapine Glenmark 200 mg prolonged-release tablets | |
Linezolid | Change notification | 01.07.2025 | Production problem | Linezolid Glenmark 600 mg film-coated tablets | |
Galantamine hydrobromide | Change notification | 01.07.2025 | Production problem | Galantamine Glenmark 16 mg hard capsules, delayed release | |
Galantamine hydrobromide | Change notification | 01.07.2025 | Production problem | Galantamine Glenmark 8 mg hard capsules, delayed release | |
Galantamine hydrobromide | Change notification | 01.07.2025 | Production problem | Galantamine Glenmark 24 mg hard capsules, delayed-release | |
Trazodone hydrochloride | Change notification | 01.07.2025 | Production problem | Trazodone Glenmark 100 mg tablets | |
Phenoxymethylpenicillin potassium | Change notification | 01.07.2025 | Other | Pen Mega – 1 A Pharma | |
Aprepitant | Change notification | 01.07.2025 | Other | Aprepilor 80 mg hard capsules | |
Aprepitant | Change notification | 01.07.2025 | Other | Aprepilor 125 mg/80 mg hard capsules | |
Haloperidol decanoate | Change notification | 01.07.2025 | Production problem | Haloperidol-neuraxpharm decanoate 50 mg/ml | |
Haloperidol decanoate | Change notification | 01.07.2025 | Production problem | Haloperidol neuraxpharm decanoate 100 mg/ml | |
Quetiapine fumarate (Ph.Eur.) | Change notification | 01.07.2025 | Other | Quetiapine-neuraxpharm 50 mg prolonged-release tablets | |
Quetiapine fumarate (Ph.Eur.) | Change notification | 01.07.2025 | Other | Quetiapine-neuraxpharm 150 mg prolonged-release tablets | |
Quetiapine fumarate (Ph.Eur.) | Change notification | 01.07.2025 | Other | Quetiapine-neuraxpharm 200 mg prolonged-release tablets | |
Quetiapine fumarate (Ph.Eur.) | Change notification | 01.07.2025 | Other | Quetiapine-neuraxpharm 300 mg prolonged-release tablets | |
Quetiapine fumarate (Ph.Eur.) | Change notification | 01.07.2025 | Other | Quetiapine-neuraxpharm 400 mg prolonged-release tablets | |
Quetiapine fumarate (Ph.Eur.) | Change notification | 01.07.2025 | Other | Quetiapine-neuraxpharm 600 mg prolonged-release tablets | |
Galantamine hydrobromide | Change notification | 01.07.2025 | Other | Galantamine-neuraxpharm 8 mg delayed-release hard capsules | |
Galantamine hydrobromide | Change notification | 01.07.2025 | Other | Galantamine-neuraxpharm 16 mg hard capsules, prolonged-release | |
Galantamine hydrobromide | Change notification | 01.07.2025 | Other | Galantamine-neuraxpharm 24 mg hard capsules, delayed-release | |
Atomoxetine hydrochloride | Change notification | 01.07.2025 | Production problem | Atomoxetine-neuraxpharm 10 mg hard capsules | |
Paliperidone palmitate | Change notification | 01.07.2025 | Other | Paliperidone AL 150 mg depot injection suspension in a prefilled syringe | |
Atomoxetine hydrochloride | Change notification | 01.07.2025 | Production problem | Atomoxetine-neuraxpharm 18 mg hard capsules | |
Paliperidone palmitate | Change notification | 01.07.2025 | Other | Paliperidone AL 75 mg depot injection suspension in a prefilled syringe | |
Atomoxetine hydrochloride | Change notification | 01.07.2025 | Production problem | Atomoxetine-neuraxpharm 25 mg hard capsules | |
Paliperidone palmitate | Change notification | 01.07.2025 | Other | Paliperidone AL 50 mg depot injection suspension in a prefilled syringe | |
Atomoxetine hydrochloride | Change notification | 01.07.2025 | Production problem | Atomoxetine-neuraxpharm 40 mg hard capsules | |
Paliperidone palmitate | Change notification | 01.07.2025 | Other | Paliperidone AL 25 mg depot injection suspension in a prefilled syringe | |
Atomoxetine hydrochloride | Change notification | 01.07.2025 | Production problem | Atomoxetine-neuraxpharm 80 mg hard capsules | |
Atomoxetine hydrochloride | Change notification | 01.07.2025 | Production problem | Atomoxetine-neuraxpharm 100 mg hard capsules | |
Pramipexole dihydrochloride monohydrate | Change notification | 01.07.2025 | Other | Pramipexole HEXAL 0.26 mg prolonged-release tablets | |
Methylphenidate hydrochloride | Change notification | 01.07.2025 | Production problem | Equasym Retard 40 mg modified-release hard capsules | |
Tranexamic acid | Change notification | 01.07.2025 | Other | Cyklokapron | |
Mupirocin calcium (Ph.Eur.) | Change notification | 30.06.2025 | Production problem | Turixin | |
Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 30.06.2025 | Other | Atorvastatin Micro Labs 10 mg film-coated tablets | |
Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 30.06.2025 | Other | Atorvastatin Micro Labs 20 mg film-coated tablets | |
Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 30.06.2025 | Other | Atorvastatin Micro Labs 30 mg film-coated tablets | |
Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 30.06.2025 | Other | Atorvastatin Micro Labs 40 mg film-coated tablets | |
Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 30.06.2025 | Other | Atorvastatin Micro Labs 60 mg film-coated tablets | |
Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 30.06.2025 | Other | Atorvastatin Micro Labs 80 mg film-coated tablets | |
Ipratropium bromide (Ph.Eur.); salbutamol sulphate | First notification | 30.06.2025 | Production problem | COMBIPRASAL 0.5 mg / 2.5 mg solution for nebulizer | |
Ipratropium bromide | First notification | 30.06.2025 | Production problem | Ipratropium bromide 125 micrograms / 1 ml ampoule | |
Ipratropium bromide | First notification | 30.06.2025 | Production problem | Ipratropium bromide 250 micrograms / 1 ml Stulln | |
Quetiapine fumarate (Ph.Eur.) | Change notification | 30.06.2025 | Other | Seroquel Prolong 400 mg prolonged-release tablets | |
Sertraline hydrochloride | Change notification | 30.06.2025 | Other | Sertraline TAD 100 mg film-coated tablets | |
Sertraline hydrochloride | Change notification | 30.06.2025 | Other | Sertraline TAD 50 mg film-coated tablets | |
Trimipramine mesilate | Change notification | 30.06.2025 | Other | Trimipramine – 1 A Pharma 40 mg/ml Oral drops, solution | |
Doxorubicin hydrochloride | Change notification | 30.06.2025 | Other | Doxorubicin HEXAL 2 mg/ml | |
Hydromorphone hydrochloride | Change notification | 30.06.2025 | Other | Hydromorphone HEXAL 2.6 mg hard capsules | |
Terbutaline sulphate (Ph.Eur.) | Change notification | 30.06.2025 | Production problem | BRICANYL 0.5 mg | |
Chlortalidone | Change notification | 30.06.2025 | Other | Chlortalidone HEXAL 25 mg tablets | |
Chlortalidone | Change notification | 30.06.2025 | Other | Chlortalidone HEXAL 50 mg tablets |
Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
larotrectinib sulfate | Capsule, hard | 30.7 mg | Anticipated | Available | Unexpected increase in consumer demand | 6/07/2025 |
benzathine benzylpenicillin tetrahydrate | Injection, suspension | 1200000 USP Unit | Current | Unavailable | Manufacturing | 4/07/2025 |
levetiracetam | Tablet, film coated | 500 mg | Anticipated | Available | Manufacturing | 4/07/2025 |
metronidazole | Tablet, uncoated | 400 mg | Current | Unavailable | Manufacturing | 4/07/2025 |
galantamine hydrobromide | Capsule, modified release | 30.756 mg | Current | Limited Availability | Manufacturing | 4/07/2025 |
quetiapine fumarate | Tablet, modified release | 460.52 mg | Current | Limited Availability | Manufacturing | 4/07/2025 |
irbesartan~hydrochlorothiazide | Tablet, film coated | 300 mg~12.5 mg | Current | Unavailable | Manufacturing | 4/07/2025 |
acarbose | Tablet | 100 mg | Anticipated | Available | Manufacturing | 4/07/2025 |
irbesartan | Tablet, film coated | 150 mg | Current | Limited Availability | Manufacturing | 4/07/2025 |
ivabradine hydrochloride | Tablet, film coated | 8.085 mg | Current | Unavailable | Manufacturing | 4/07/2025 |
ivabradine hydrochloride | Tablet, film coated | 5.39 mg | Current | Unavailable | Manufacturing | 4/07/2025 |
flucloxacillin sodium monohydrate | Injection, powder for | 544.1 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 4/07/2025 |
sitagliptin hydrochloride monohydrate | Tablet, film coated | 56.69 mg | Current | Unavailable | Manufacturing | 4/07/2025 |
daptomycin | Injection, powder for | 500 mg | Resolved | Available | Manufacturing | 4/07/2025 |
dacarbazine | Injection, powder for | 200 mg | Current | Limited Availability | Manufacturing | 4/07/2025 |
spironolactone | Tablet, film coated | 100 mg | Resolved | Available | Manufacturing | 4/07/2025 |
pioglitazone hydrochloride | Tablet, uncoated | 16.53 mg | Current | Unavailable | Commercial Changes / Commercial viability | 4/07/2025 |
lidocaine hydrochloride | Injection, solution | 10 mg/mL | Anticipated | Available | Manufacturing | 3/07/2025 |
venlafaxine hydrochloride | Capsule, modified release | 169.71 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 3/07/2025 |
risperidone | Tablet, film coated | 2 mg | Anticipated | Available | Manufacturing | 3/07/2025 |
naloxone hydrochloride dihydrate~buprenorphine hydrochloride | Soluble Film | 2.44 mg~8.64 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 3/07/2025 |
ezetimibe~rosuvastatin calcium | Tablet~Tablet, film coated | 10 mg~41.583 mg | Current | Limited Availability | Manufacturing | 3/07/2025 |
bosentan monohydrate | Tablet, film coated | 129.082 mg | Anticipated | Available | Manufacturing | 3/07/2025 |
midazolam | Injection, solution | 15 mg | Resolved | Available | Manufacturing | 3/07/2025 |
ezetimibe~atorvastatin calcium trihydrate | Tablet, multilayer | 10 mg~86.8 mg | Resolved | Available | Manufacturing | 3/07/2025 |
isotretinoin | Capsule, soft | 10 mg | Anticipated | Available | Manufacturing | 3/07/2025 |
tranexamic acid | Tablet, film coated | 500 mg | Anticipated | Available | Manufacturing | 3/07/2025 |
encorafenib | Capsule, hard | 50 mg | Current | Limited Availability | Manufacturing | 3/07/2025 |
midodrine hydrochloride | Tablet | 5 mg | Current | Unavailable | Manufacturing | 3/07/2025 |
erlotinib hydrochloride | Tablet, film coated | 27.32 mg | Anticipated | Available | Unexpected increase in consumer demand | 3/07/2025 |
levothyroxine sodium | Tablet | .2 mg | Resolved | Available | Manufacturing | 3/07/2025 |
rosuvastatin calcium | Tablet, film coated | 41.68 mg | Resolved | Available | Manufacturing | 3/07/2025 |
sildenafil citrate | Tablet, film coated | 70.24 mg | Current | Unavailable | Unexpected increase in consumer demand | 3/07/2025 |
fentanyl citrate | Injection, solution | 785 microgram | Current | Unavailable | Manufacturing | 3/07/2025 |
cytarabine | Injection, solution | 100 mg/mL | Resolved | Available | Manufacturing | 3/07/2025 |
lidocaine hydrochloride | Injection, solution | 10 mg/mL | Resolved | Available | Manufacturing | 3/07/2025 |
lidocaine hydrochloride monohydrate | Injection, solution | 20 mg/mL | Anticipated | Available | Manufacturing | 3/07/2025 |
lidocaine hydrochloride monohydrate | Injection, solution | 10 mg/mL | Current | Unavailable | Manufacturing | 3/07/2025 |
lidocaine hydrochloride monohydrate | Injection, solution | 10 mg/mL | Current | Limited Availability | Manufacturing | 3/07/2025 |
losartan potassium | Tablet, film coated | 50 mg | Resolved | Available | Unexpected increase in consumer demand | 3/07/2025 |
zolpidem tartrate | Tablet, film coated | 10 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 3/07/2025 |
Rubella virus~live varicella vaccine~Mumps virus~Measles virus | Injection, powder for | 1000 CCID50~1995 PFU~25119 CCID50~1000 CCID50 | Current | Unavailable | Manufacturing | 2/07/2025 |
zolpidem tartrate | Tablet, film coated | 10 mg | Resolved | Available | Manufacturing | 2/07/2025 |
acetylcholine chloride | Solution, powder for irrigation | 10 mg/mL | Current | Unavailable | Manufacturing | 2/07/2025 |
metformin hydrochloride | Tablet, film coated | 500 mg | Current | Unavailable | Manufacturing | 2/07/2025 |
metformin hydrochloride | Tablet, film coated | 500 mg | Current | Unavailable | Manufacturing | 2/07/2025 |
sulfamethoxazole~trimethoprim | Injection, concentrated | 80 mg/mL~16 mg/mL | Current | Limited Availability | Manufacturing | 2/07/2025 |
busulfan | Injection, concentrated | 60 mg | Resolved | Available | Manufacturing | 2/07/2025 |
ceftazidime pentahydrate~avibactam sodium | Injection, powder for | 2329.7 mg~543.5 mg | Anticipated | Available | Unexpected increase in consumer demand | 2/07/2025 |
teriflunomide | Tablet, film coated | 14 mg | Current | Unavailable | Manufacturing | 2/07/2025 |
levothyroxine sodium | Tablet, uncoated | .05 mg | Current | Limited Availability | Manufacturing | 2/07/2025 |
levothyroxine sodium | Tablet, uncoated | .075 mg | Current | Limited Availability | Manufacturing | 2/07/2025 |
verapamil hydrochloride | Tablet, modified release | 240 mg | Current | Limited Availability | Manufacturing | 1/07/2025 |
ciprofloxacin hydrochloride | Tablet, film coated | 555 mg | Current | Unavailable | Manufacturing | 1/07/2025 |
ropivacaine hydrochloride | Injection, solution | 150 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 1/07/2025 |
nicorandil | Tablet | 20 mg | Current | Limited Availability | Manufacturing | 1/07/2025 |
nicorandil | Tablet | 10 mg | Current | Unavailable | Manufacturing | 1/07/2025 |
leuprorelin acetate~bicalutamide | Injection, modified release~Tablet, film coated | 22.5 mg~50 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 1/07/2025 |
mesalazine | Tablet, enteric coated | 250 mg | Current | Unavailable | Manufacturing | 1/07/2025 |
metformin hydrochloride | Tablet, film coated | 1000 mg | Current | Limited Availability | Manufacturing | 1/07/2025 |
trimethoprim | Tablet, uncoated | 300 mg | Resolved | Available | Manufacturing | 1/07/2025 |
pomalidomide | Capsule, hard | 2 mg | Current | Unavailable | Manufacturing | 1/07/2025 |
carbidopa monohydrate~levodopa | Tablet, uncoated | 26.9 mg~100 mg | Resolved | Available | Manufacturing | 1/07/2025 |
estradiol~norethisterone acetate | Drug delivery system, transdermal | .62 mg~2.7 mg | Resolved | Available | Manufacturing | 1/07/2025 |
norethisterone acetate~estradiol | Drug delivery system, transdermal | 4.8 mg~.512 mg | Resolved | Available | Manufacturing | 1/07/2025 |
minocycline hydrochloride dihydrate | Tablet, film coated | 54 mg | Resolved | Available | Manufacturing | 1/07/2025 |
estradiol hemihydrate | Drug delivery system, transdermal | 2.32 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 1/07/2025 |
methylphenidate hydrochloride | Capsule, modified release | 20 mg | Anticipated | Available | Manufacturing | 1/07/2025 |
nizatidine | Capsule | 150 mg | Current | Limited Availability | Manufacturing | 1/07/2025 |
live varicella vaccine | Injection, powder for | 2700 PFU/mL | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 30/06/2025 |
pentetic acid | Injection, powder for | 5 mg | Current | Unavailable | Manufacturing | 30/06/2025 |
medronic acid | Injection, powder for | 10 mg | Current | Unavailable | Manufacturing | 30/06/2025 |
sodium fluoride | Injection, concentrated | 1 mg/mL | Current | Unavailable | Manufacturing | 30/06/2025 |
ciprofloxacin hydrochloride | Tablet, film coated | 277.5 mg | Current | Unavailable | Manufacturing | 30/06/2025 |
ciprofloxacin hydrochloride | Tablet, film coated | 832.5 mg | Current | Unavailable | Manufacturing | 30/06/2025 |
midazolam | Injection, solution | 5 mg | Current | Unavailable | Manufacturing | 30/06/2025 |
tranexamic acid | Injection, solution | 1000 mg | Current | Unavailable | Commercial Changes / Commercial viability | 30/06/2025 |
deoxycholic acid | Injection, solution | 10 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 30/06/2025 |
voriconazole | Injection, powder for | 200 mg | Current | Unavailable | Commercial Changes / Commercial viability | 30/06/2025 |
solifenacin succinate | Tablet | 5 mg | Current | Limited Availability | Manufacturing | 30/06/2025 |
oxycodone hydrochloride | Injection, solution | 10 mg/mL | Current | Unavailable | Commercial Changes / Commercial viability | 30/06/2025 |
amikacin sulfate | Injection, solution | 333.76 mg/mL | Current | Unavailable | Manufacturing | 30/06/2025 |
ezetimibe~atorvastatin calcium trihydrate | Tablet, film coated | 10 mg~20.681 mg | Resolved | Available | Manufacturing | 30/06/2025 |
paclitaxel | Injection, powder for | 100 mg | Current | Limited Availability | Manufacturing | 30/06/2025 |
finasteride | Tablet, film coated | 1 mg | Anticipated | Available | Manufacturing | 30/06/2025 |
adapalene | Gel | 1 mg/g | Resolved | Available | Manufacturing | 30/06/2025 |
Teriparatide | Injection, solution | 250 microgram/mL | Anticipated | Available | Manufacturing | 30/06/2025 |